Description: Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Best Beauty Stocks to Buy Right Now. TheFly reported on January 8, 2026, that BofA reduced the price target for Hims & Hers Health, Inc. (NYSE:HIMS) to $29 from $32. It retained an Underperform rating on the stock. The firm claims that the consensus expectations […]

Description: CVS Health is scheduled to release its fourth-quarter results next month, with analysts anticipating a double-digit decline in the company’s bottom-line figure.

Description: The CVS Health Foundation granted the American Diabetes Association® (ADA) $2.6 million to expand its maternal health initiative to two additional communities within New York City. This expansion builds on the tremendous success of the program's first 18 months, which improved early gestational diabetes (GDM) screening and care coordination for hundreds of patients at Wyckoff Heights Medical Center in Brooklyn. The next phase will bring these life-saving interventions to support more families ac

Description: Most readers would already know that CVS Health's (NYSE:CVS) stock increased by 1.6% over the past month. However, its...

Description: The healthcare services company says it expects to bring in over $50 billion in specialty revenue in fiscal 2026.

Description: Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

Description: CVS Health Corporation (NYSE:CVS) is one of the stocks from different market sectors that Jim Cramer commented on. Cramer made bullish comments on the stock during the episode, as he remarked: “The sixth best sector and the only other sector to finish 2025 up double digits was healthcare, which finished up 12.5%. Coming into last […]

Description: CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Description: Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Description: The latest investor updates on stocks that are trending on Monday.

Description: CVS Health Corporation (NYSE:CVS) is one of the most undervalued blue chip stocks to buy now. On January 6, 2026, Bernstein increased its price target on CVS Health Corporation (NYSE:CVS) from $87 to $91, while reiterating a ‘Market Perform’ rating. The investment firm expects a broader inflection in the government-managed care organization (MCO) sector beginning […]

Description: Key Insights Institutions' substantial holdings in CVS Health implies that they have significant influence over the...

Description: We recently published 9 Stocks Jim Cramer Talked About. CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer talked about. CVS Health Corporation (NYSE:CVS) is one of the largest pharmaceutical chains in America. Its shares are up by 73% over the past year. JPMorgan named the firm as a Top Pick in December, as […]

Description: Customers with commercial insurance will pay a minimum of $25 for a one-month supply, while the cost for those without insurance starts at $149 a month.

Description: CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 11th, 2026, at 8:00 a.m. ET to discuss fourth quarter and full year 2025 financial results.

Description: CHICAGO, January 08, 2026--Aetna Better Health of Illinois and Blueberry Pediatrics provide Cook County families with 24/7 remote pediatric care and home diagnostic medical kits

Description: There is an even more important question to address.

Description: CVS Health (CVS) closed at $79.79 in the latest trading session, marking a -1.13% move from the prior day.

Description: CVS Health recently announced that its board approved a quarterly dividend of US$0.665 per share, payable on February 2, 2026 to shareholders of record on January 22, 2026, while also advancing an AI-focused digital retail media rollout and expanding its pharmacy benefit management footprint. By pairing an AI-native engagement platform and 11,000 in-store digital screens with a new CalPERS PBM mandate and Medicare services via SilverScript, CVS Health is emphasizing technology-enabled...

Description: Why CVS Health (CVS) Is On Investors’ Radar Today CVS Health (CVS) is drawing fresh attention after recent share price moves and updated return figures, prompting investors to reassess how its current valuation lines up with the company’s scale and profitability profile. See our latest analysis for CVS Health. Recent share price momentum has been gradual, with a 6.33% 1 month share price return and the current US$80.42 level sitting against a much stronger 83.18% 1 year total shareholder...

Description: If you are wondering whether CVS Health at around US$80.42 is offering fair value or a potential bargain, it helps to break the story down into what the recent share performance and underlying business are telling you. The stock has returned 0.7% over the last week, 6.3% over the last month, 0.4% year to date and 83.2% over the last year. This gives a mixed picture when you set that against the 3 year return of negative 0.5% and 5 year return of 24.0%. Recent headlines around CVS Health have...

Description: CHICAGO, January 06, 2026--Wayspring, an organization dedicated to advancing care for substance use disorder (SUD), and Aetna Better Health® of Illinois, a CVS Health® company, have teamed up to deliver a new model of recovery care for Illinois Medicaid members — one that shows up, breaks down barriers and makes lasting recovery possible.

Description: CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on February 2, 2026, to holders of record on January 22, 2026.

Description: Novo Nordisk (NVO) said Monday that its Wegovy pill, the first oral medicine for obesity in the US,

Description: Cash has flowed into oil stocks following the U.S.’s seizing of Venezuelan President Nicolás Maduro.

Description: McKesson posts a strong fiscal second quarter, lifts full-year EPS outlook, and shows how specialty growth and automation are reshaping its earnings power.

Description: Eli Lilly stock is falling as rival Novo Nordisk hit a milestone in the area of weight-loss drugs. But Lilly has a rival drug in the pipeline.

Description: European stock markets closed mostly higher in Monday trading with the Stoxx Europe adding 0.9%, Ger

Description: Novo Nordisk’s shares rallied after the drugmaker said its new Wegovy weight-loss pill is now broadly available in the U.S., following regulatory approval last month. The Wegovy product is the first GLP-1 pill approved specifically for weight loss. It will tap into what analysts expect will be substantial demand from consumers seeking an alternative to the injections that have dominated the anti-obesity market to date.

Description: Novo Nordisk’s Wegovy weight-loss pill is now broadly available across the U.S., two weeks after it received U.S. regulatory approval, the Danish drugmaker said.

Description: Wegovy® pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 medicine in a pill for the first time. This advancement opens new possibilities for the more than 100 million Americans living with obesity.2 Wegovy® pill was approved on December 22, 2025 and is used with a reduced calorie diet and increased physical activity for adults with obesity, or with overweight who also have weight-related medical problems, to help them lose weight and keep i

Description: In the last year, multiple insiders have substantially increased their holdings of CVS Health Corporation ( NYSE:CVS...

Description: CVS Health Corporation (NYSE:CVS) is included among the 20 Best Performing Dividend Stocks in 2025. The stock dropped 43% in 2024, then swung the other way with an 80.5% gain this year. Even after that run, Wall Street still sees room to move. The average analyst price target points to another 19% upside.Earlier in December, […]

Description: The stock market powered through a year of volatility to mark a strong finish in 2025. While artificial intelligence was a theme that dominated 2025, many winners were instead linked to healthcare and banking. Case in point, CVS Health : The stock was among the names that had their best year in two decades.

Description: Uber Technologies and the Braves are on the latest Forgotten Forty list of value stocks from John Boyar.

Description: Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

Description: CVS Health Corporation (NYSE:CVS) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 12, Bernstein raised the firm’s price target on CVS Health Corporation (NYSE:CVS) to $87 from $86 and kept a Market Perform rating after what it described as a very positive Investor Day. The firm pointed to […]

Description: Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Description: Why the debate matters.

Description: The latest trading day saw CVS Health (CVS) settling at $79.12, representing a +1.38% change from its previous close.

Description: The simplest way to invest in stocks is to buy exchange traded funds. But investors can boost returns by picking...

Description: In June, self-made billionaire Mark Cuban lit up X with a series of posts that didn't call for sweeping legislation, but something simpler: accountability. "When a large employer pays so little that their full-time employees qualify for Medicaid, or any public assistance, we the taxpayers are effectively subsidizing that big company. That's wrong," he wrote. Cuban wasn't pitching policy reform—he was drawing a line between capitalism and corporate freeloading. "The best way to reduce the cost of

Description: Investing.com -- Morgan Stanley is asking whether Unitedhealth Group (NYSE:UNH) could become “the CVS of 2026,” arguing that recent actions suggest a clear intention toward margin repair even at the expense of membership growth.

Description: So you are wondering whether CVS Health at around $77.79 is still a smart buy after its big run, or if you are showing up late to the party, this breakdown will help you separate real value from just a strong share price chart. After a choppy few years, the stock has snapped back sharply, up 75.9% year to date and 82.9% over the last 12 months, even though the last week was a modest setback with a 2.1% dip and the last month saw a quieter 1.6% gain. That rebound has come as investors refocus...

Description: The stocks listed here trade at forward earnings multiples of less than 18.

Description: Paramount Skydance (PSKY), Intel (INTC), and Estée Lauder (EL) are just some of the S&P 500 (^GSPC) components that gained in 2025, rebounding from negative returns in 2024. Yahoo Finance Markets and Data Editor Jared Blikre, who also hosts Yahoo Finance's Stocks in Translation podcast, takes a closer look at some of 2025's best comebacks. Catch more Stocks in Translation, with new episodes every Tuesday and Thursday. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.

Description: DHR sees Biotechnology core revenues rise 6.5% in Q3 2025, fueled by bioprocessing demand, with approximately 5% growth expected in Q4.

Description: The healthcare sector is a great place to find quality income stocks, and these two appear to be strong picks.

Description: In December 2025, CVS Health raised its 2025 guidance to at least US$400.0 billion in revenue and higher GAAP operating income, while also forecasting a US$5.73 billion goodwill impairment. At the same time, CVS Health issued new 2026 guidance, signaling a reset of reported earnings around large non-cash charges amid mounting regulatory scrutiny and its Healthy 2030 sustainability agenda. We’ll now examine how CVS Health’s higher revenue and earnings guidance, despite sizable goodwill...

Description: Sree Chaguturu, CVS Health Executive Vice President and President of Health Care Delivery, says the fee for service model is broken and that value based care is critical to the future of health care. He speaks with Romaine Bostick and Katie Greifeld on "The Close."

Description: Oscar Health rallied on Wednesday morning amid an intraparty GOP rebellion over ACA subsidies, though other S&P 500 health care stocks lost more ground. Centene, the top ACA Marketplace insurer by membership, and HCA Healthcare, the largest U.S. hospital operator, fell for a third straight session, with much of the damage coming Tuesday as House Speaker Mike Johnson signaled he wouldn't allow a vote on a bipartisan compromise plan to extend the subsidies. On Monday, Morgan Stanley downgraded HCA to underweight from equal weight on Monday, saying its high valuation is at a peak as Washington reins in growth of the ACA Marketplaces and Medicaid supplemental payments.

Description: Health insurers are regaining pricing control and margin visibility, putting UnitedHealth, CVS Health and Centene back in focus as managed care regains its pulse.

Description: Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Description: American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., provides customers with greater flexibility to pay their water and wastewater bill, adding additional payment options on its online customer portal, MyWater, and in person by scanning their bill's unique barcode at participating stores, such as Walmart, CVS, Family Dollar and more.

Description: CVS Health shares jump after the company begins offering MMR vaccines across South Carolina pharmacies and clinics post a measles outbreak.

Description: Companies like Cigna and CVS are promising simpler prices, but the behind-the-scenes system remains complex.

Description: CVS Health (CVS) just put fresh numbers on the table, raising its outlook for 2025 and sketching out higher earnings in 2026, and investors are paying attention because this guidance is tied to tangible progress in Aetna, pharmacy benefits and a new AI driven consumer platform. See our latest analysis for CVS Health. The guidance upgrade has been matched by price action, with CVS delivering a roughly 79 percent year to date share price return and a 59 percent one year total shareholder...

Description: As South Carolina public health officials work to stop the spread of measles following the current outbreak in the state, CVS Health® (NYSE:CVS) is offering the measles-mumps-rubella (MMR) vaccine to residents. Both CVS Pharmacy® stores and MinuteClinic® walk-in medical clinics in the area have vaccines available to help protect patients against measles.

Description: CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently commented on. Cramer praised the company’s CEO during the episode, as he commented: “This stock has become the best performer in the healthcare sector under CEO David Joyner and shot up another 2% today as management laid out some bullish long-term earnings targets.” […]

Description: Exec Edge hosted a fireside chat on Dec. 8 from the Nasdaq Marketsite with Chris Searles, co-founder and Chief Executive Officer, and Trevor Smith, co-founder and Chief Technology Officer of DxCheck. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed the key challenges the company is solving for patients, caregivers and marketing partners, […]

Description: Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index adding 1.6% and the

Description: CVS Health (CVS) is entering 2026 with momentum and visibility into mid-teens earnings growth throug

Description: CVS Health (CVS) is highlighting clearer long-term earnings prospects and solid performance across i

Description: CVS Health Corporation (NYSE:CVS) is among the cheap healthcare stocks to buy heading into 2026. On December 4, Bernstein SocGen Group lifted the price target on CVS Health Corporation (NYSE:CVS) to $86.00 from $77.00, while reaffirming a ‘Market Perform’ rating on the stock. The firm attributed the improved guidance to the company’s Aetna business unit, […]

Description: CVS is bringing together its disparate businesses onto one platform, and giving its rivals the option to add their products and services as well. The goal is to improve consumers’ health engagement while generating more revenue.

Description: CVS Health’s narrative has shifted with a slightly higher fair value estimate, nudging from about $91.50 to roughly $92.40 per share as analysts factor in modestly stronger long term revenue growth assumptions. While the discount rate has ticked up from around 7.18% to about 7.35%, reflecting a marginally higher required return amid lingering industry risks, updated research still leans constructive given improving earnings visibility and expectations for medium term margin recovery. Stay...

Description: <body><p>STORY: EDITOR'S NOTE:THIS STORY WAS REFILED TO CORRECT A LINE SAYING THE COMPANY'S PROFIT FORECAST TOPPED ESTIMATES</p><p>Shares of CVS rose as much as five percent Tuesday morning after the company raised its 2025 profit outlook for the fourth time.</p><p>CEO David Joyner said at the company’s investor day that CVS has delivered on its promises this year and will now focus on improving consumer experiences across the business.</p><p>He added, "We've invested heavily in what I would believe is the challenge in the marketplace, which is a lack of trust."</p><p>The upbeat outlook caps a year in which Joyner pushed through a sweeping overhaul, which involved cutting costs, exiting underperforming markets, and strengthening management to revive investor confidence.</p><p>CVS shares have responded with gains of more than 70% this year.</p><p>CVS said in May that it plans to exit the market for Obamacare health insurance plans in 2026, as rising medical costs have pressured health insurers in recent quarters.</p><p>The company expects its Aetna insurance business and CVS Caremark pharmacy benefit management unit to drive growth, as their profit margins are expected to return to target levels.</p><p>Analysts at Leerink Partners said in a note that, "CVS' near-term momentum should set the stage for what remains a robust growth recovery story.”</p></body>

Description: A decline in shares of JPMorgan Chase weighs on the Dow Jones Industrial Average, with the Federal Reserve expected to lower interest rates on Wednesday. Plus, CVS Health shares gain on an improved outlook.

Description: 🔎 Nvidia (NVDA): President Trump said he would let Nvidia export its H200 chip to China, and the U.S. would receive a 25% cut. He said the government would take a similar approach to AMD (AMD) and Intel (INTC) exports.

Description: US equity benchmarks ended mixed Tuesday as traders digested fresh labor market data, a day before t

Description: CVS Health shares climbed Tuesday after the health conglomerate raised its full-year outlook and outlined plans for a new AI platform to boost engagement.

Description: Nvidia slips after President Donald Trump says he plans to allow the company to sell its more advanced AI chip to China.

Description: Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index down 0.6% and th

Description: US benchmark equity indexes were mixed intraday as investors evaluated fresh labor market data, whil

Description: All three major US stock indexes were edging higher in late-morning trading on Tuesday after the Fed

Description: Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 3.2% in the morning session after the company raised its financial guidance for 2025 and provided a strong forecast for 2026 at its Investor Day event.

Description: Jim Cramer, the charismatic host of CNBC’s Mad Money, has become a household name for investors seeking bold, actionable insights. Known for his high-energy delivery and colorful metaphors, Cramer blends deep market knowledge with an ability to distill complex financial trends into digestible advice. While he doesn’t exclusively focus on dividend stocks, his analysis often ... Cramer Loves These Dividend Stocks

Description: CVS Health issued an update to its full-year guidance Tuesday ahead of its annual investor day, pointing to stronger performance in 2025 than previously expected. CVS now sees total revenue of at least $400 billion, up from $397.3 billion previously and above Wall Street’s forecast for $398.4 billion, according to FactSet. The owner of the drugstore chain and insurance giant Aetna guided for adjusted earnings in the range of $6.60 to $6.70 a share, compared with a prior range of $6.55 to $6.65.

Description: The healthcare giant expects its turnaround efforts to pay off as it raised its full-year outlook and expects that momentum to carry over into 2026.

Description: Morning Brief host Julie Hyman outlines three trending tickers on Yahoo Finance's platform during Tuesday's trading session: CVS Health (CVS), Home Depot (HD), and AutoZone (AZO). To watch more expert insights and analysis on the latest market action, check out more Morning Brief.

Description: CVS Health (CVS) lifted its full-year outlook on Tuesday amid ongoing efforts to strengthen its core

Description: The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.02%, while the actively

Description: Today at its 2025 Investor Day, CVS Health® (NYSE: CVS) (the "Company") will launch its strategy to deliver best-in-class execution, transform consumer experiences, be the partner of choice, and harness unique enterprise capabilities to address challenges across the health care system. With a powerful collection of diversified businesses that work together across the health care landscape – Aetna, CVS Caremark, CVS Pharmacy and Health Care Delivery – CVS Health and its over 300,000 dedicated col

Description: Vancouver, British Columbia--(Newsfile Corp. - December 8, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) ("TempraMed" or the "Company"), a medical technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce a major commercial milestone as part of its broader global expansion strategy: its flagship products, the VIVI Cap and VIVI EPI, are now available through Maccabi Healthcare Services, Israel's second-largest health maintenance...

Description: If you are wondering whether CVS Health is still a bargain after its big run this year, or if the easy money has already been made, you are not alone. That is exactly what we are going to explore. The stock has slipped about 3.9% over the last week and is down 1.7% over the past month. Year to date it is still up 73.6%, with a 40.8% gain over the last year despite a softer three‑year track record. Recent headlines have focused on CVS Health doubling down on its strategy as an integrated...

Description: CVS Health® (NYSE: CVS) today released its inaugural National Economic Impact Report demonstrating the positive economic impact that the company has in communities across the country.

Description: CVS Health's (CVS) constructive outlook is supported by ongoing recovery in its Medicare Advantage b

Description: SANTA MONICA, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- JAKKS Pacific, Inc. (NASDAQ: JAKK), a leading designer and marketer of toys, and The Hershey Company, one of the world’s largest confectionery brands, announced today a new partnership that will bring the beloved Hershey branding to JAKKS Pacific’s popular Charming line of small dolls and collectibles, marking the first-ever confection-themed expansion of the fashionable mini-doll brand. The collection will consist of eight SKUs featuring d

Description: Aetna®, a CVS Health® company (NYSE: CVS), today announces key milestones in support of the company's comprehensive strategy announced in June to remove friction in the healthcare system and improve the experience for healthcare professionals and their patients.

Description: Investing.com -- Mizuho has refreshed its monthly Americas Top Picks list, adding new high-conviction ideas selected by its U.S. equity analysts.

Description: HCA Healthcare and CVS Health are firing on all cylinders.

Description: CVS Health Corporation (NYSE:CVS) is included among the 15 Dividend Stocks that Outperform the S&P 500. On November 13⁠,​ Well‌s Fargo analyst Stephen Ba‌xter lowered‍ the firm’s pric⁠e target on CVS Health Corporation (NYSE:CVS) to⁠ $102 from⁠ $103 while maintaining an Overwe‍ight rating. The analyst‌ noted that Q3 results wer⁠e generally solid, t⁠hough the bul⁠lish […]

Description: CVS Health (CVS) is still "long crowded and well-liked" by investors ahead of next week's investor e

Description: Harrow, Inc. has secured a key win as CVS’s pharmacy benefit manager replaced Xiidra with Harrow’s dry eye drug Vevye on its Tier 1 formulary, and the company recently presented at BTIG Ophthalmology Day and the Piper Sandler Healthcare Conference in New York. This formulary upgrade at the largest U.S. PBM could materially improve patient access and prescription volumes for Vevye, reinforcing Harrow’s position in branded ophthalmic pharmaceuticals. We’ll now examine how CVS elevating Vevye...

Description: Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Description: Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index and the Health C

Description: Health care stocks declined Tuesday afternoon, with the NYSE Health Care Index down 0.5% and the Hea

Description: Cornerstone Community Development, in cooperation with Winterwood, CVS Health® (NYSE: CVS) and other community organizations, invites the public and media to a special event celebrating the transformation of one of Huntington's most historic properties. The Prichard Centennial Residential Reveal & Next-Phase Preview will be held on Thursday, December 4, 2025, at 1:30 p.m. at 601 9th Street, Huntington, WV 25701.

Description: Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.

Description: CVS Health announced that its Board of Directors has elected President and CEO David Joyner as Chair of the Board, effective January 1, 2026, with current Executive Chair Roger Farah remaining on the Board and Michael Mahoney continuing as Lead Independent Director. This move consolidates board and executive leadership under Joyner, reflecting board confidence in his healthcare expertise and recent operational improvements since his appointment as CEO in October 2024. We’ll examine how the...

Description: This healthcare stock has struggled this year, but things are suddenly looking up.

Description: CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Description: CVS posts a sharper MBR as PDR impacts ease and government business strengthens while maintaining a cautious full-year outlook.

Description: Over the past year, CVS stock has outpaced the healthcare sector, garnering positive analyst sentiment and demonstrating sustained momentum.

Description: CVS Health (CVS) shares have been moving recently, capturing the attention of investors curious about what might be driving this latest price activity. The stock has witnessed some shifts over the past month, which has sparked ongoing conversation around the company’s valuation and growth outlook. See our latest analysis for CVS Health. CVS Health’s share price has picked up steam lately, gaining over 10% in the last 90 days and notching a sharp 4.3% rise this week alone. While it is still...

Description: CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.

Description: CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.

Description: CVS Health stock has seen its consensus analyst price target edge down slightly from $91.52 to $91.48, a reflection of tempered optimism following recent earnings. Analysts cite a mix of upbeat and cautious factors shaping their outlooks; the modest adjustment captures both lingering industry challenges and growing confidence in the company’s execution. Stay tuned to learn how you can keep informed on further shifts in analyst sentiment as the narrative for CVS Health continues to...

Description: CVS gains momentum with record revenues, stronger guidance and a cheaper valuation, standing out in the retail pharmacy comparison with WMT.

Description: Taxes and inflation are packing a one-two punch.

Description: Healthcare politics and investing might as well be living in alternate universes. President Trump and some Republicans have been describing Obamacare as a gravy train for insurers. Trump’s latest broadside slammed “big, fat, rich insurance companies who have made trillions,” and he urged Congress to send healthcare subsidies directly to patients instead.

Description: Valuations don't usually matter — until they do. And suddenly some S&P 500 investors seem to be paying at least some attention.

Description: If you have ever wondered whether CVS Health could be a hidden gem or just fairly priced, you are not alone. Let's break down whether the stock deserves a spot on your radar. Over the past year, CVS shares have climbed an impressive 38.9%, with an even more dramatic YTD surge of 72.0%. The last month has seen a pullback of 8.4%. Much of this recent movement came after CVS announced its expanded partnership with a major insurer and a handful of strategic healthcare acquisitions. These moves...

Description: The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.

Description: CVS Health® (NYSE: CVS) today announced that its Board of Directors has elected President and Chief Executive Officer David Joyner as Chair of the Board, effective January 1, 2026. Following the effective date of this appointment, Michael Mahoney will continue to serve as the Board's Lead Independent Director, and Roger Farah, who is currently serving as Executive Chair of the Board, will continue to serve on the Board.

Description: CVS Health's Aetna debuts an embedded generative AI assistant designed to simplify benefits navigation and elevate the consumer health experience.

Description: CVS Pharmacy® today announced the launch of Joyward™, a new line of decor, gifts and more to celebrate the joy of every season.

Description: Over the past decade, pharmacy giant Walgreens, with over 8,000 stores nationwide, has struggled financially due to several factors. The company’s finances have been impacted by opioid-related claims and litigation settlements, costing it billions of dollars. Walgreens has also been affected by ...

Description: CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Description: Aetna, a CVS Health® company (NYSE: CVS), is launching a market-leading generative AI-powered conversational experience in its digital channels that will simplify health care, allowing members to quickly and easily navigate their benefits for a personalized experience.

Description: UnitedHealth Group Incorporated (NYSE:UNH) is one of the stocks Jim Cramer expressed his thoughts on. A caller asked for Cramer’s opinion of the stock, and he replied: “I’m a buyer. What happened in UnitedHealth, where they did some, where there was some chicanery, seems to be the, the authorities don’t seem to be looking at […]

Description: TDOC accelerates global growth as expanding international operations and rising overseas revenues bolster its profitability outlook.

Description: CVS posts record Q3 revenues and a sharp EPS jump, lifting its 2025 outlook, while momentum builds across Aetna, Health Services and Pharmacy.

Description: CVS Health Corporation (NYSE:CVS) is one of the best blue-chip stocks to buy now. On November 3, 2025, TD Cowen lifted its price target on the stock to $100 from $99, while keeping a Buy rating. The move followed management’s updated guidance, which narrowed the expected GAAP diluted loss per share to between $0.24 and […]

Description: Insights from Glenview Capital Management's Third Quarter 2025 13F Filing

Description: SAP gains momentum as cloud ERP growth, strong pipelines and AI-driven solutions anchor its latest featured research report.

Description: CVS Health recently reported a robust third quarter, surpassing analyst expectations with a significant increase in adjusted earnings per share and raising full-year 2025 guidance, driven by strong performance in key segments and successful integration of acquired Rite Aid and Bartell Drugs prescription files. These developments reflect CVS Health's renewed operational momentum under new leadership, as the company sharpens its focus on more profitable growth areas and leverages its expanded...

Description: Eli Lilly Dumps CVS Health Plan After Coverage Rift on Weight-Loss Drugs

Description: Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index gaining 1.6% and th

Description: UnitedHealth shares dipped earlier this week as Trump’s populist healthcare remarks rattled insurers, but fundamentals and long-term guidance may tell a more resilient story.

Description: These companies are demonstrating their ability to deal with significant business risks.

Description: Last year was a bad one for these stocks, but buying them on weakness would have proven to be a great move for investors.

Description: Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including Infineon Technologies (IFX.DE, IFNNY) raising its revenue guidance on AI data center demand, Chevron (CVX) choosing West Texas as the site of its first AI data center project, and Eli Lilly (LLY) reportedly dropping CVS Health's (CVS) drug plan from employee coverage. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.

Description: CVS raises its full-year EPS outlook after a strong quarter, driven by gains across all segments and solid pharmacy growth.

Description: The company replaced its CEO last year, and the turnaround has been going well.

Description: Teladoc Health is expanding its AI-powered virtual care capabilities as the telemedicine market surges toward massive U.S. growth.

Description: CVS Health (CVS) recently posted a net loss for the third quarter, cut full-year earnings guidance, and reported a major goodwill impairment. These developments have investors rethinking the company’s near-term outlook and business momentum. See our latest analysis for CVS Health. While CVS Health’s hefty goodwill impairment and reduced earnings outlook have weighed on sentiment, the 20.6% share price return over the last 90 days suggests some investors see value after a tough stretch. Total...

Description: President Donald Trump wrote that "hundreds of billions" in federal funding should be shifted from "money sucking" health insurers to the public.

Description: CVS Health® (NYSE: CVS) will hold its Investor Day on December 9th, 2025. Members of management will discuss the Company's strategy and will provide financial guidance for 2025 and 2026.

Description: TRIP announces a $40 million funding round – led by high-profile names such as Joe Jonas, Alessandra Ambrosio, Paul Wesley, Ashley Graham, and consumer fund Coefficient Capital. TRIP, the fastest growing drinks brand in the US this year (Spins) is on track to deliver $100 million in annual revenue this year and is predicted to reach $200 million in 2026.

Description: CVS Health stock has recently seen its Fair Value Estimate rise from $86.20 to $91.52, reflecting increased confidence in the company's near-term earnings outlook. This price target adjustment follows strong quarterly results and sector trends, which indicate both momentum and ongoing market challenges. Stay tuned for strategies on how to keep up with the evolving narrative around CVS Health’s valuation and prospects. Analyst Price Targets don't always capture the full story. Head over to our...

Description: Healthcare stocks in the S&P 500 offer an average dividend yield of 1.8%.

Description: President Donald Trump wrote that "hundreds of billions" in federal funding should be shifted from "money sucking" health insurers to the public.

Description: The company's prospects are looking up.

Description: CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently shared thoughts on. Cramer discussed the company’s “reinvention,” as he said: “Sadly, this tale of reinvention doesn’t happen very often, but when it does, I celebrate it. For example, I really like what David Joyner’s doing with the turnaround at CVS. Value creation, […]

Description: Wondering if CVS Health is a true bargain or just another healthcare stock? You're in the right place to find out what the numbers actually say about its value. Despite some short-term ups and downs, with a 2.2% gain over the past month and a significant 32.9% rally over the last year, CVS Health has caught the eye of both growth seekers and value hunters. Recent headlines highlight CVS’s ongoing push into primary care through acquisitions and collaborative healthcare initiatives. This has...

Description: The boss of the London Stock Exchange's parent company is to urge Rachel Reeves to take fresh steps in the budget to incentivise as much as £100bn of additional investment by UK pension funds into the domestic stock market. Sky News has learnt that a letter from David Schwimmer, the LSEG chief executive, has amassed more than 250 signatures from companies including pubs group Mitchells & Butlers, construction firm Kier and fresh food producer Bakkavor.

Description: Teladoc Health's Q3 results beat estimates, but revenues dipped and losses widened, attributed to soft performance at BetterHelp.

Description: CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Description: Candy Ventures Sarl, a portfolio of companies founded by Nick Candy, took legal action against Dutch businessman Robert Bonnier and his firm.

Description: CVS Health’s third quarter was shaped by strong top-line momentum across its core businesses, notably pharmacy and health insurance, with management attributing results to improved execution in retail pharmacy, market share gains, and early progress on Aetna’s operational turnaround. CEO David Joyner emphasized that CVS’s “diversified business and progress on becoming the most trusted health care company” helped offset reimbursement pressures and challenges in Health Care Delivery. The company’s

Description: The new hires will report to Daniel Heaf, chief executive officer of Bath & Body Works.

Description: Maly Bernstein, who spent four years leading the Macy’s, Inc. banner, has been named chief commercial officer.

Description: Some financial successes are enough to impress even the world's richest man.

Description: CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is boosting the overall contribution to support Feeding America. The in-store campaign, hosted at CVS Pharmacy locations nationwide, gave customers a simple and impactful way to contribute to the movement to end hunger in their own communities. CVS Health has also committed over $2 million in 2025 to address food insecurity, continuing a long history of suppo

Description: CVS Health (CVS) reported a net profit margin of just 0.1%, a notable drop from last year’s 1.4%. Over the last five years, the company’s earnings have declined by 12.5% annually, and the most recent 12 months were hit by a one-off $6.3 billion loss. Despite these setbacks, analysts expect earnings to rebound sharply, forecasting 40.76% annual growth going forward. Revenue is expected to rise 4.6% per year, trailing the broader U.S. market’s pace. Investors will be weighing the promise of...

Description: A strong quarter clouded by one costly accounting charge.

Description: Gilead Sciences reported third-quarter results that surpassed Wall Street expectations late Thursday, amid a close focus on the launch of the company’s promising new HIV medicine. Gilead shares are up 30% this year, largely on enthusiasm for Yeztugo, a twice-yearly HIV prevention shot that the FDA approved in June. Gilead said Thursday that sales of Yeztugo had been $39 million in the third quarter.

Description: The bond sale comes a day after Chief Executive Officer Mark Zuckerberg warned that the company would spend even more aggressively on artificial intelligence in the coming year. Morgan Stanley expects big tech companies known as hyperscalers to spend about $3 trillion on infrastructure like data centers between now and the end of 2028, with roughly half of that likely financed through the corporations’ cash flows. Thursday’s bond sale is the biggest high-grade note offering since 2023, when Pfizer Inc. sold $31 billion of debt.

Description: Shares of diversified healthcare company CVS Health (NYSE:CVS) fell 4.3% in the morning session after the company reported a significant $5.7 billion goodwill impairment charge related to its Health Care Delivery business, which overshadowed otherwise strong third-quarter results.

Description: Investing.com -- Meta Platforms Inc. has received orders of about $125 billion for its corporate bond sale, setting a new record for such an offering, according to a Bloomberg report released Thursday. The announcement of the bond offering sent the company’s shares as much as 13% during Thursday session.

Description: CVS Health's (CVS) "strong" Q3 performance reinforces the company's position as a leading Medicare A

Description: The company said that profit margins for its pharmacy-benefit-services division would slide over the next two years.

Description: It's a turnaround for the 'broke' generation.

Description: Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.61 per share was 18.3% above analysts’ consensus estimates.

Description: CVS Health Corporation (NYSE:CVS) is included among the 13 Most Undervalued Dividend Stocks to Buy According to Wall Street Analysts. CVS Health Corporation (NYSE:CVS) is a diver⁠sif⁠ie​d healthcare c‌ompany that runs pharmacies and retail stor‍es whil‌e offering various health services, such as prescription management, vaccinations, and di‌agnostic testing. On October 24⁠, UBS‌ increa⁠sed its pr⁠ice targ‌et […]

Description: Cigna has outperformed peers as the managed-care industry faces policy challenges. Affordable Care Act subsidies are set to expire and premiums for next year are up 26%.

Description: CVS Health announced a $5.7 billion write-down primarily related to Oak Street Health, an operator of medical clinics servicing the elderly, on Wednesday as part of its third-quarter earnings release. Investors may recall that CVS—a drugstore operator, health insurer, drug benefits, and health services provider—acquired Oak Street in a $10.7 billion all-cash deal in 2023. Oak Hill operated 239 medical clinics, or what the company calls value-based primary care centers, at the end of 2024 and served 500,000 patients last year.

Description: On Tuesday, UnitedHealth Group Chief Executive Stephen Hemsley told investors the company is “positioning for durable and accelerating growth in 2026 and beyond.” One way it is doing that: cutting its Medicare business down to size. Bobby Hunter, who oversees UnitedHealth care’s government programs, said the insurer expects its Medicare membership to fall by about one million members next year.

Description: All three major US stock indexes were up in late-morning trading on Wednesday, as investors look ahe

Description: CVS Health (CVS) stock is in focus after the company reported record-high revenue and lifted its full-year outlook. Grey Ghost Capital healthcare investor and Tenet Healthcare (THC) board member, Meghan Fitzgerald, joins Market Catalysts to discuss the earnings print and CVS's ongoing turnaround efforts. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.

Description: CVS Health (NYSE: CVS) reported third-quarter results this morning that beat adjusted earnings expectations but delivered a mixed message on operations and cash flow. Adjusted EPS came in at $1.60, well above the $1.37 consensus estimate. Revenue reached $102.87 billion, topping the $98.85 billion expectation and books sales grew 7.8% year over year as all ... CVS Posts Strong Q3 Earnings, but Shares Show Little Movement

Description: CVS Health raised its guidance for the rest of the year, boosted by improved performance at its Aetna insurance unit.

Description: CVS Health stock has been on the mend somewhat after falling from its 2022 high, but questions remain about its ongoing recovery.

Description: The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Description: CVS shares slip even though Q3 earnings and revenues beat estimates, with the company boosting its 2025 EPS outlook.

Description: CVS Health rode double-digit sales growth from drugstores and its pharmacy benefits management business to a better-than-expected third quarter. The company said Wednesday that it filled more prescriptions at drugstores, partially due to added business from customers of the defunct Rite Aid chain. CVS Health recently said it will close 16 underperforming clinics early next year.

Description: An increase in the deduction limit sounds like great news for high earners — but take cover, because a high-speed tax penalty is headed your way.

Description: CVS Health (CVS) delivered earnings and revenue surprises of +17.65% and +4.66%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: The main US stock measures were pointing higher in Wednesday's premarket activity as traders await t

Description: Investing.com - CVS Health lifted its annual profit outlook, but flagged a $5.7 billion charge linked to an impairment test which showed that the fair value of its struggling health care delivery division was below its carrying value.

Description: Diversified healthcare company CVS Health (NYSE:CVS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.60 per share was 17.9% above analysts’ consensus estimates.

Description: WOONSOCKET, R.I. (AP) — CVS Health Corporation (CVS) on Wednesday reported a loss of $3.98 billion in its third quarter. On a per-share basis, the Woonsocket, Rhode Island-based company said it had a loss of $3.13. Earnings, adjusted for one-time gains and costs, were $1.60 per share.

Description: The healthcare giant beat Wall Street expectations in the third quarter, but reported a net loss after recording a $5.7 billion charge linked primarily to decelerating clinic growth at Oak Street Health.

Description: CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended September 30, 2025.

Description: CV S Health stock has been on the mend somewhat after falling from its 2022 high, but questions remain about its ongoing recovery.

Description: CVS' Pharmacy & Consumer Wellness arm gains traction from tech upgrades, new Rite Aid assets and its evolving CostVantage model.

Description: Diversified healthcare company CVS Health (NYSE:CVS) will be reporting results this Wednesday before market hours. Here’s what investors should know.

Description: CVS Health Corporation (NYSE:CVS) is one of the stocks in focus in the game plan Jim Cramer shared. Cramer made some positive comments on the stock. He said: “Next, Wednesday got me trembling in anticipation. Why? Well, this morning has a sure winner in CVS, at least from my point of view. Now, I’m betting […]

Description: CVS outpaces FMS in share gains and valuation appeal, with stronger earnings momentum and expanding health services driving its edge.

Description: As it turns out, there's lots you can learn from teachers.

Description: Recent updates have brought a modest increase in CVS Health’s Fair Value Estimate, rising to $86.20 from $83.79, and a slight decrease in the discount rate to 7.19 percent from 7.24 percent. Analysts attribute these changes to renewed confidence in the company’s execution, improved visibility in key Medicare metrics, and cautious optimism about the recovery in managed care margins. Stay tuned to discover how investors can stay ahead as expectations shift as the outlook for CVS Health stock...

Description: Don't let your money languish in an account that doesn't give you anything back.

Description: You don't need to turn to prospecting to see the benefits the shiny metal can bring.

Description: Looking beyond Wall Street's top-and-bottom-line estimate forecasts for CVS Health (CVS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

Description: In the latest trading session, CVS Health (CVS) closed at $81.07, marking a -1.15% move from the previous day.

Description: Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Description: There are some economic factors the boomer finance expert may be overlooking.

Description: CVS Health (CVS) shares slipped after the company posted earnings that initially looked solid. However, management’s comments on persistent Medicaid margin pressures quickly became the focus. Investors are now scrutinizing the outlook for its government insurance business. See our latest analysis for CVS Health. While CVS Health’s latest quarter was overshadowed by tough Medicaid headlines, its 39.6% share price surge over the last 90 days and a strong 85.5% gain year-to-date suggest momentum...

Description: CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Description: Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

Description: InnerScope Hearing Technologies Inc. (OTC: INND), a publicly traded innovator in hearing health ("InnerScope"), today announced its pivotal role in the pending acquisition of OTCHealth Inc. ("OTCHealth") by Ainnova Tech Inc. ("Ainnova"), a global leader in AI-powered early disease detection. This transaction marks a major milestone for InnerScope, as it leverages its established retail distribution agreements and technology pipeline to drive growth and innovation across the U.S. and global healt

Description: HOUSTON, TX / ACCESS Newswire / October 22, 2025 / Ainnova Tech Inc., (" Ainnova ") a global leader in artificial intelligence for early disease detection, today announced the signing of a Letter of Intent to acquire OTCHealth Inc., (" OTCHealth ") ...

Description: CVS Health is slated to release its fiscal third-quarter earnings later this month, and analysts are anticipating a notable double-digit growth in profits.

Description: CVS vs. HQY: Which Stock Is the Better Value Option?

Description: The health insurer’s results looked strong at first glance, but the stock fell as management discussed margins in its Medicaid business.

Description: Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Description: SAN FRANCISCO, October 21, 2025--Rune Labs, the leader in precision medicine for neurology, today announced the appointment of Adam Pellegrini as an independent member of its Board of Directors. Pellegrini is a recognized leader in AI-driven digital health, with more than two decades of experience building and scaling platforms that bridge technology, patients, and healthcare systems. His background spans executive roles at Kaia Health, Jasper Health, CVS Health, Fitbit, Walgreens Boots Alliance

Description: Costco (NASDAQ:COST), the warehouse club best known for its bulk bargains and $1.50 hot dogs, is expanding its pharmacy into fast-growing weight-loss drug market. The company is now selling Ozempic and Wegovy — two of the most in-demand prescription ...

Description: CVS Health (CVS) closed at $82.52 in the latest trading session, marking a +1.41% move from the prior day.

Description: Nearly all 55 million Medicare users overpay for prescriptions. Expert Katy Votava explains how to compare Part D plans and save thousands.

Description: O's focus on non-discretionary tenants drives steady cash flow and keeps its portfolio nearly full even in uncertain markets.

Description: DHR gears up for Q3 results with steady earnings estimates and mixed segment trends across Life Sciences, Biotechnology and Diagnostics.

Description: CVS Pharmacy completes the Rite Aid deal, adding 63 stores, 626 pharmacies and nine million patients to its national care network.